Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
Sarfez Pharmaceuticals
Sarfez Pharmaceuticals
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
No data
Company Revenue
No data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
Soaanz
Torsemide
2021-06-14
2033
Heart failure
,
Hypertension
,
Chronic kidney failure
,
Liver cirrhosis
,
Nephrotic syndrome
,
Edema
,
Ascites
,
Pulmonary edema
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Torsemide
food-drug interactions
,
chronic renal insufficiency
,
kidney diseases
,
body weight
,
body weight changes
,
overactive urinary bladder
,
urinary incontinence
,
heart failure
Sodium chloride
hypertension
,
pulmonary hypertension
,
ischemia
,
hypoxia
,
brain diseases
,
brain ischemia
,
brain hypoxia-ischemia
,
necrotizing enterocolitis
,
enterocolitis
,
heart diseases
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use